Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCS-5 in Male Oligoasthenospermia
NCT01016340Phase 2Terminated
- Sponsor
- Health Ever Bio-Tech Co., Ltd.
- Start
- Dec 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MCS-5 in oligoasthenospermia (OA), sponsored by Health Ever Bio-Tech Co., Ltd.. Started Dec 2009; status: terminated.
02
Drugs
MCS-5
03
Conditions
oligoasthenospermia (OA)
Beyond the preview
Go deeper on NCT01016340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016340.